5/A//SEC Filing
Byrne Joseph A. 5/A
Accession 0001437749-21-013626
CIK 0001653821other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 8:30 AM ET
Size
6.9 KB
Accession
0001437749-21-013626
Insider Transaction Report
Form 5/AAmended
CEN BIOTECH INCCENBF
Byrne Joseph A.
DirectorChief Executive Officer*
Transactions
- Award
Common Stock
2017-11-30+1,250,000→ 1,353,265 total - Award
Common Stock
2017-11-30+20,000→ 1,353,265 total
Footnotes (2)
- [F1]1,270,000 shares of common stock of the Issuer were granted by the issuer to the reporting person on November 30, 2017, pursuant to two restricted stock agreements pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
- [F2]1,353,265 shares were beneficially owned by the Reporting Person of which 76,123 shares were issuable upon conversion of a convertible note held by the Reporting Person at 12/31/2017.
Documents
Issuer
CEN BIOTECH INC
CIK 0001653821
Entity typeother
Related Parties
1- filerCIK 0001736911
Filing Metadata
- Form type
- 5/A
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 8:30 AM ET
- Size
- 6.9 KB